FDA Import Refusal 112-1726740-0/1/1 — Bhakti Capital
The FDA refused shipment 112-1726740-0/1/1 from Bhakti Capital (Indonesia) on Nov 19, 2003. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75
Refusal details
- Date
- Nov 19, 2003
- Country
- Indonesia
- Product Category
- Drugs and Biologics
- Product Code
- 66VCA99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75